TotalMarketCap

Nervgen Pharma

NGENNasdaq CanadaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$140.977 M

$1.31 -2.96%

Close of 6 Nov 2026

As of 6 Nov 2026, Nervgen Pharma (NGEN) has a market capitalization of $141.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

79,649,257

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #266MacrogenicsMGNX$143.3M
  2. #267Alx OncologyALXO$143.0M
  3. #268Nervgen PharmaNGEN$141.0M
  4. #269Veraxa Biotech AG - Post de-SPACVRXA$139.4M
  5. #270Satellos BioscienceMSLE$135.8M

What if Nervgen Pharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$262,384.46

Per share 200,293× higher

Bitcoin $1.53T

$14,197.17

Per share 10,838× higher

Apple $5.02T

$46,607.97

Per share 35,579× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Nervgen Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.